Related Experiment Video
Updated: Jan 31, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?
Ezra Linley1, Abigail Bell2, Jenna F Gritzfeld3
1Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK. ezra.linley@phe.gov.uk.
The 13-valent pneumococcal conjugate vaccine shows limited effectiveness against pneumococcal serotype 3 invasive disease and carriage. Unique capsule characteristics and assay limitations may explain this reduced vaccine efficacy.
Area of Science:
- Vaccinology
- Microbiology
- Immunology
Background:
- The 13-valent pneumococcal conjugate vaccine (PCV13) is widely used for preventing pneumococcal diseases.
- Limited efficacy of PCV13 against Streptococcus pneumoniae serotype 3 has been observed in multiple countries.
Purpose of the Study:
- To review evidence on the effectiveness of PCV13 against serotype 3 invasive pneumococcal disease and carriage.
- To discuss potential reasons for the limited efficacy of the serotype 3 component.
- To evaluate the reliability of serotype 3 detection in diagnostic assays.
Main Methods:
- Systematic review of studies from seven countries (Denmark, France, Greece, Portugal, Sweden, UK, US).
- Analysis of serotype 3 capsule characteristics.
- Evaluation of Luminex multiplex assay performance for serotype 3 detection.
Main Results:
- Evidence indicates limited or no effectiveness of PCV13 against serotype 3 invasive pneumococcal disease and carriage across multiple nations.
- Serotype 3 possesses unique capsular characteristics, including abundant expression and potential release of free polysaccharide, contributing to immune evasion.
- The Luminex multiplex assay shows inferior inter-laboratory reproducibility for serotype 3, questioning the reliability of results.
Conclusions:
- The efficacy of the 13-valent pneumococcal conjugate vaccine against serotype 3 remains a significant concern.
- Unique biological properties of the serotype 3 capsule may underlie its resistance to vaccine-induced immunity.
- The reliability of current diagnostic assays for serotype 3 requires further investigation, potentially impacting future vaccine development and public health strategies.
Related Concept Videos
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Specific Heat
For example, increasing the temperature of one gram of water by 1°C requires one calorie of heat energy and can be written as 1 cal/g-°C, or...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Piaget's Stage 3 of Cognitive Development
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
Density, Specific Weight, Specific Gravity and Compressibility of Fluid
Specific weight represents the weight per unit volume and is calculated by multiplying...
Cell Specific Gene Expression

